Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
With fresh capital and a new pipeline strategy, Replicor aims to tackle chronic viral infections and rare liver …
ExoGene’s novel delivery platform earns RMAT status for its lead candidate EXG-401, targeting neuroinflammation and motor neuron survival …
Personalized mRNA cancer vaccine combined with Keytruda delivers sustained recurrence-free survival in high-risk melanoma patients, reinforcing immunotherapy’s future.
Already a subscriber? Log in